Structure-thermodynamics-relationships of hepatitis C viral NS3 protease inhibitorsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92020-04-013PREAI
PBI-200: A novel, brain penetrant, next generation pan-TRK kinase inhibitorCANCER RESEARCHIF16.62019-07-0110PRE
Integrated Strategies for Identifying Leads That Target the NS3 Helicase of the Hepatitis C VirusJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-01-2719PREAI
Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver DistributionJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-03-2831PREAI
Molecular Mechanism by Which a Potent Hepatitis C Virus NS3-NS4A Protease Inhibitor Overcomes Emergence of ResistanceJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92013-02-0120OAAI
Evaluation of Phosphatidylinositol-4-Kinase IIIα as a Hepatitis C Virus Drug TargetJOURNAL OF VIROLOGYIF3.82012-11-0156OAAI
The Liver Partition Coefficient-Corrected Inhibitory Quotient and the Pharmacokinetic-Pharmacodynamic Relationship of Directly Acting Anti-Hepatitis C Virus Agents in HumansANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52012-10-0119OAAI
In Vitro Resistance Profile of the Hepatitis C Virus NS3 Protease Inhibitor BI 201335ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52012-01-0144OAAI
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionJOURNAL OF HEPATOLOGYIF332011-06-01101PREAI
Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335JOURNAL OF BIOLOGICAL CHEMISTRYIF3.92011-04-0149OAAI
Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A ProteaseANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-11-01106OAAI
Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)JOURNAL OF MEDICINAL CHEMISTRYIF6.82010-08-1797PREAI
CHARACTERIZATION OF RESISTANT MUTANTS SELECTED IN VITRO BY THE HCV NS3/4A PROTEASE INHIBITOR BI 201335JOURNAL OF HEPATOLOGYIF332010-04-015PREAI
PRECLINICAL CHARACTERIZATION OF NON-COVALENT HCV NS3/4A PROTEASE INHIBITOR BI 201335JOURNAL OF HEPATOLOGYIF332010-04-015OAAI
Optimization and determination of the absolute configuration of a series of potent inhibitors of human papillomavirus type-11 E1-E2 protein-protein interaction:: A combined medicinal chemistry, NMR and computational chemistry approachBIOORGANIC & MEDICINAL CHEMISTRYIF32007-04-0140PRE
Biphenylsulfonacetic acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-12-0140OAAI
Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061JOURNAL OF VIROLOGYIF3.82004-07-1585OAAI
Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 Transactivation domain by photoaffinity labeling and mass spectrometryANALYTICAL CHEMISTRYIF6.72004-02-2523PREAI
Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitorJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92004-02-0196OAAI
Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicaseJOURNAL OF MEDICINAL CHEMISTRYIF6.82003-12-09139PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向